Murray Stahl's NVS Position Overview
Murray Stahl (via Horizon Kinetics Asset Management LLC) currently holds 11,797 shares of Novartis AG (NVS) worth $1.51 M, representing 0.02% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Murray Stahl has maintained a long-term strategic position in NVS, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2017, adding 2,444 shares. Largest reduction occurred in Q1 2023, reducing 6,650 shares.
Analysis based on 13F filings available since 2013 Q2
Murray Stahl's Novartis (NVS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Novartis (NVS) Trades by Murray Stahl
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +33,035 | Add 0.00% | 33,034 | $63.36 |
| Q3 2013 | -335 | Reduce 1.01% | 32,699 | $68.75 |
| Q1 2014 | +65 | Add 0.20% | 32,764 | $76.18 |
| Q2 2014 | +74 | Add 0.23% | 32,838 | $81.13 |
| Q4 2014 | -64 | Reduce 0.19% | 32,774 | $83.02 |
| Q1 2015 | -2,028 | Reduce 6.19% | 30,746 | $88.37 |
| Q2 2015 | -223 | Reduce 0.73% | 30,523 | $88.10 |
| Q3 2015 | +1,562 | Add 5.12% | 32,085 | $82.37 |
| Q1 2016 | +558 | Add 1.74% | 32,643 | $64.91 |
| Q4 2016 | -4,910 | Reduce 15.04% | 27,733 | $65.27 |
| Q2 2017 | +2,444 | Add 8.81% | 30,177 | $74.79 |
| Q3 2017 | -558 | Reduce 1.85% | 29,619 | $76.94 |
| Q4 2017 | -56 | Reduce 0.19% | 29,563 | $75.23 |
| Q1 2018 | -139 | Reduce 0.47% | 29,424 | $72.46 |
| Q2 2018 | -310 | Reduce 1.05% | 29,114 | $67.70 |
| Q4 2018 | -229 | Reduce 0.79% | 28,885 | $76.89 |
| Q1 2019 | +28,886 | Add 0.00% | 28,885 | $86.13 |
| Q2 2019 | -3,752 | Reduce 12.99% | 25,133 | $91.31 |
| Q4 2019 | -32 | Reduce 0.13% | 25,101 | $94.70 |
| Q1 2020 | -291 | Reduce 1.16% | 24,810 | $82.47 |
| Q2 2020 | -2,055 | Reduce 8.28% | 22,755 | $87.32 |
| Q3 2020 | +560 | Add 2.46% | 23,315 | $86.94 |
| Q4 2020 | -1,255 | Reduce 5.38% | 22,060 | $94.42 |
| Q2 2021 | -750 | Reduce 3.40% | 21,310 | $91.22 |
| Q3 2021 | -380 | Reduce 1.78% | 20,930 | $81.80 |
| Q4 2021 | -880 | Reduce 4.20% | 20,050 | $87.48 |
| Q3 2022 | +1,100 | Add 5.49% | 21,150 | $76.03 |
| Q4 2022 | -2,300 | Reduce 10.87% | 18,850 | $90.72 |
| Q1 2023 | -6,650 | Reduce 35.28% | 12,200 | $92.00 |
| Q4 2023 | -403 | Reduce 3.30% | 11,797 | $100.97 |
| Q3 2024 | +347 | Add 2.94% | 12,144 | $115.02 |
| Q4 2024 | +403 | Add 3.32% | 12,547 | $97.31 |
| Q2 2025 | -403 | Reduce 3.21% | 12,144 | $121.01 |
| Q3 2025 | -347 | Reduce 2.86% | 11,797 | $128.24 |
Murray Stahl's Novartis Investment FAQs
Murray Stahl first purchased Novartis AG (NVS) in Q2 2013, acquiring 33,034 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Murray Stahl has held Novartis AG (NVS) for 50 quarters since Q2 2013.
Murray Stahl's largest addition to Novartis AG (NVS) was in Q2 2013, adding 33,034 shares worth $2.09 M.
According to the latest 13F filing for Q3 2025, Murray Stahl's firm, Horizon Kinetics Asset Management LLC, owns 11,797 shares of Novartis AG (NVS), valued at approximately $1.51 M.
As of the Q3 2025 filing, Novartis AG (NVS) represents approximately 0.02% of Murray Stahl's publicly disclosed stock portfolio, making it one of their key holdings.
Murray Stahl's peak holding in Novartis AG (NVS) was 33,034 shares, as reported at the end of Q2 2013.